Synopsis
Authorizing pharmaceutical manufacturers and representatives of pharmaceutical manufacturers to engage in the truthful promotion of off-label uses for drugs, biological products, and devices; and prohibiting certain persons from taking certain enforcement and disciplinary action against a pharmaceutical manufacturer, representative of a pharmaceutical manufacturer, or health care provider for engaging in a truthful promotion of an off-label use of a drug, biological product, or device.
Committees
- Original:
- Health and Government Operations
Committee Testimony
Details
Bill File Type: Regular
Effective Date(s): October 1, 2024
History
Toggle History Dropdown
File Code
Toggle Filecode Dropdown
Subjects
Toggle Subjects Dropdown
Statutes
Toggle Statutes Dropdown
(
21-218.1 )
Last Updated: 5/28/2024 2:22 PM